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Abstract
Background: Bone marrow-derived mesenchymal stem cells (BMSCs) are a widely researched
adult stem cell population capable of differentiation into various lineages. Because many promising
applications of tissue engineering require cell expansion following harvest and involve the treatment
of diseases and conditions found in an aging population, the effect of donor age and ex vivo handling
must be understood in order to develop clinical techniques and therapeutics based on these cells.
Furthermore, there currently exists little understanding as to how these two factors may be
influenced by one another.
Results: Differences in the adipogenic, chondrogenic, and osteogenic differentiation capacity of
murine MSCs harvested from donor animals of different age and number of passages of these cells
were observed. Cells from younger donors adhered to tissue culture polystyrene better and
proliferated in greater number than those from older animals. Chondrogenic and osteogenic
potential decreased with age for each group, and adipogenic differentiation decreased only in cells
from the oldest donors. Significant decreases in differentiation potentials due to passage were
observed as well for osteogenesis of BMSCs from the youngest donors and chondrogenesis of the
cells from the oldest donors.
Conclusion: Both increasing age and the number of passages have lineage dependent effects on
BMSC differentiation potential. Furthermore, there is an obvious interplay between donor age and
cell passage that in the future must be accounted for when developing cell-based therapies for
clinical use.
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Background
As the prospect of stem cell based therapeutics entering
the clinic becomes more of a reality, researchers and clini-
cians must account for variability among stem cell popu-
lations used to evaluate therapeutic modalities in
regenerative medicine and also among the patient popu-
lations that will potentially provide autogenous or alloge-
neic stem cells [1-3]. As hinted by the role of stem cell
senescence and dysfunction in natural aging [4-7], donor
or patient age will be a critical factor that must be
accounted for in clinical and laboratory evaluations of
stem cell based technology.
There is currently little consensus and in many cases con-
flicting reports regarding the effect of donor age and cell
processing on adult mesenchymal stem cell (MSC) func-
tion. A number of studies have previously shown no age
related differences in differentiation using human BMSCs
[8-11]; however, many studies demonstrating no change
in differentiation have found changes in proliferation,
attachment, senescence or self-renewal in mouse [12], rat
[13,14], and human [15,16] BMSCs. Using mouse adi-
pose derived MSCs (AdMSCs), Shi et al. found an age
related decrease in adipogenic differentiation but no dif-
ference in osteogenic differentiation [17], while Wall et al.
found that with increasing passage, human AdMSCs
tended towards osteogenic differentiation over adipo-
genic differentiation [18]. Similarly, work by Kirkland et
al. found that advanced age in rats results in decreased lev-
els of mRNA associated with adipogenic differentiation in
preadipocytes [19], a change that has since been linked to
decreased expression of CCAAT/enhancer binding protein
(C/EBP)-α [20], caused by overexpression of C/EBP
homologous protein, and increased release of TNFα [21].
In contrast, studies have found an age related decrease in
osteoblastic but not adipogenic differentiation in BMSCs
from rats [22] and humans [23,24]. Numerous other stud-
ies have found significantly decreased differentiation
capability with increasing BMSC donor age, particularly
for osteogenic [25-27], chondrogenic [28], and myogenic
[29] differentiation.
Another important parameter that must be considered,
particularly because of decreased proliferation and the
propensity towards senescence observed in cells from
aged donors, is the effect of cell passage on the differenti-
ation capability of adult MSCs. BMSCs largely lose their in
vitro differentiation capability at or around the 6th passage
[30,31], but there is evidence of adverse changes as early
as the first [32] or second passage [27]. In vivo benefits
from MSC based therapies are also abated with increased
passage [33]. Interestingly, however, while some reports
indicate an age related decline in adipogenic differentia-
tion capability for AdMSCs [17] and a similar passage
related decline in osteogenic differentiation capability
with a simultaneous enhancement in adipogenic differen-
tiation [31], previous results and hypotheses suggested
that with increasing passage cells progressed through a
lineage hierarchy, whereby bone marrow derived progen-
itors would retain a capacity towards osteogenic differen-
tiation and adipose derived progenitors towards
adipogenicity [34]. Recent comparisons of human BMSC
and AdMSC differentiation [35] and transcriptomes [36]
supports this hierarchical model of preferential or
retained differentiation.
In the only published study that examined the combined
effects of increased in vitro passages and donor age on
BMSC differentiation, Stenderup et al. examined osteo-
genic and adipogenic differentiation of human BMSCs
[16]. They found decreased osteoblastic and adipogenic
differentiation with increased number of passages for
BMSCs from both young and old donors, but did not
observe effects on differentiation when comparing across
the two age groups.
To simultaneously evaluate the effects of both age and
passage on BMSC differentiation, we utilized a full facto-
rial study design investigating the adipogenic, chondro-
genic, and osteogenic differentiation of mouse BMSCs
from postnatal, adult, and aged mice at passage 1 and pas-
sage 6. The objective of such a study design was to provide
a controlled analysis of two variables (age and passage)
and possible interaction between these crucial factors in
developing adult stem cell based therapeutics and for
which no consensus exists regarding their role in MSC dif-
ferentiation.
Methods
Experimental design
This study uses a factorial design to investigate the effects
of donor age and cell passage on BMSC differentiation
into 3 mesenchymal lineages. Murine bone marrow
derived mesenchymal stem cells were harvested from
donors aged 6 days (postnatal), 6 weeks (adult), and 1
year (aged) and cultured through either 1 or 6 passages
before differentiation was induced. The harvested and cul-
tured cells used were the adherent population of cells
within the bone marrow and are often referred to as either
marrow stromal cells or mesenchymal stem cells (a sub-
population of marrow stromal cells). For this study, the
adherent cell population examined will be referred to as
bone marrow derived mesenchymal stem cells or BMSCs.
BMSC harvest and culture
All experiments followed protocols approved by the Ani-
mal Experiment and Care Committee of Shanghai Jiao
Tong University School of Medicine. Postnatal (6-day
old), adult (6-weeks old), and aged (1-year old) trans-
genic male eGFP C57Bl/6 mice were obtained from a localBMC Cell Biology 2008, 9:60 http://www.biomedcentral.com/1471-2121/9/60
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breeder colony. Mice were euthanized via cervical disloca-
tion and bilateral thoracotomy and then immersed in
75% ethanol for 15 minutes. The bilateral femurs and tib-
ias were aseptically excised, stripped of connective tissues,
and the epiphyses and metaphyses were then removed.
The remaining diaphyses were placed in a culture dish
with 7.5 ml sterile PBS, and the bone marrow was flushed
from the shafts via 3–5 minutes of vigorous pipetting of
the PBS. The PBS/marrow suspension was then filtered
through a 70-μm cell strainer (BD Biosciences, Missis-
sauga, ON, Canada), collected and centrifuged for 5 min-
utes at 524 × g. After removal of the supernatant, the
resulting pellet was resuspended in α-MEM supplemented
with 10% fetal bovine serum (FBS, HyClone, Logan, UT),
2 mM L-glutamine and plated at a density of 1.7–2.0 × 104
cells/cm2. Media were changed every 3 days, and cells
were passaged when confluent (~5 × 104 cells/cm2) with
0.05% trypsin in 0.02% ethylenediaminetetraacetic acid
(Gibco, Canada). Cells were replated at a density of 3 ×
103 cells/cm2. First and sixth passage cells were used as
indicated for all experiments. Each experiment was per-
formed with cells pooled from 2–7 mice for each age
group. Experiments were repeated in triplicate using dif-
ferent batches of marrow isolates.
Cell attachment and proliferation
After harvesting and resuspension, cells from postnatal,
adult, and aged mice were plated individually in wells of
6-well tissue culture plates at a density of 1 × 104 cells/
cm2. At 1/2, 1, 2, 4, 8, 16, and 24 hours after plating,
media were gently aspirated and the remaining cells were
fixed with 4% paraformaldehyde (Sigma, St. Louis, MO)
in phosphate buffered saline (PBS) for 15 minutes. Cell
adhesion was measured by counting the total cell number
per well under fluorescence.
For proliferation, first passage cells from postnatal, adult,
and aged mice were plated individually at 2 × 103 cells/
cm2 in wells of 6-well tissue culture plates. At days 1, 2, 4,
6, and 8 cells were trypsinized and counted using a hem-
acytometer.
Attachment and proliferation assays were performed in
triplicate. Cell doublings were calculated as [37]: dou-
blings = log2 (number of cells at passage/number of cells
seeded).
Adipogenic differentiation and characterization
As previously described [38], the first or the sixth passage
cells were seeded in 2 wells each of a 6-well plate at a den-
sity of 3000 cells/cm2. Cells were maintained for 24 hours
in regular culture media, after which adipogenic differen-
tiation was induced using Dulbecco's modified Eagle
medium (DMEM) supplemented with 10% FBS, 0.5 mM
isobutylmethylxanthine, 10 μM insulin, 1 μM dexameth-
asone, and 200 μM indomethacin (all from Sigma) for 3
weeks with full medium changes performed every 3 days.
2 control wells were maintained in DMEM with 10% FBS
over the same time course. Each experiment was repeated
in triplicate, resulting in 6 total wells for adipogenic differ-
entiation and 6 control wells.
Differentiated and control wells were stained with Oil Red
O. At 3 weeks post-induction, wells were gently rinsed
with PBS and then fixed with cold 4% paraformaldehyde
for 10 minutes. Wells were then washed with 60% isopro-
pyl alcohol (Sigma), incubated for 5 minutes at room
temperature in 2% (w/v) Oil Red O reagent (Sigma), and
then washed once with isopropyl alcohol followed by
repeated washes with distilled water.
For each well, 3 fields were randomly chosen and exam-
ined by light and fluorescence microscopy. The number of
total cells per field was determined under fluorescence fol-
lowed by determination of the number of cells containing
Oil Red O stained inclusions. A cell containing a visibly
stained vacuole was considered to be positively stained.
Additionally, for each view the percent area of positive
staining was determined using ImageJ (NIH, Bethesda,
MD). The area stained was determined by quantifying the
actual area stained rather than the area covered by cells
containing stained vacuoles. The average percentage was
determined from total 3 views of each well and means
plus standard deviation were derived from the average
percentage of total six wells.
Chondrogenic differentiation and characterization
As previously described [38], following monolayer culture
until the first or the sixth passage, cells were trypsinized,
counted, and centrifuged into pelletted micromass cul-
tures (5 × 106 cells/pellet) in 15 ml conical tubes (BD Bio-
sciences). After centrifugation and culture in regular
culture media for 24 hours, chondrogenesis was induced
using low glucose DMEM supplemented with 10% FBS,
10 ng/ml TGF-β1, 100 ng/ml IGF (Peprotech, Rocky Hill,
NJ), and 10 nM dexamethasone (Sigma). Cells were cul-
tured in induction or control media (low glucose DMEM
with 10% FBS only) in incubators with the conical tube
lids loosely fastened for 3 weeks and half media were
changed every other day. Four pellets (2 for induction, 2
for control) per age/passage batch were cultured, and each
batch was repeated in triplicate.
Following culture, 3 pellets from each group were ana-
lyzed for type II collagen expression and glycosaminogly-
can (GAG) quantification. Immunohistochemical
staining was performed as previously described [39].
Briefly, pellets were fixed with 4% paraformaldehyde for
2 h and embedded in Tissue-Tek OCT (Fisher Scientific,
Pittsburgh, PA) and sliced into 10 μm thick sections. Sam-BMC Cell Biology 2008, 9:60 http://www.biomedcentral.com/1471-2121/9/60
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ples were blocked and incubated overnight at 4°C in
1:100 diluted mouse anti-Collagen-II (Lab Vision, Fre-
mont, CA) in 1% bovine serum albumin (Sigma) PBS
solution. Samples were then incubated with horseradish
peroxidase (HRP)-conjugated goat anti-mouse antibody
(DAKO, Carpinteria, CA) diluted in phosphate buffered
solution (PBS, 1:100) for 30 minutes at room temperature
and developed with diaminobenzidine tetrachloride
(DAB). Cells were counterstained with hematoxylin.
Slides were also stained with Safranin O by being fixed for
10 minutes in 10% formalin in PBS, rinsed with distilled
water, and then stained for 2 minutes with 6% Safranin O
(Sigma) in distilled water.
Sulfated GAG production was measured from the remain-
ing 3 pellets per group using an Alcian blue binding assay
as previously described [40].
Osteogenic differentiation and characterization
As previously described [38], the first or the sixth passage
cells were seeded in 2 wells each of a 6-well plate at a den-
sity of 3000 cells/cm2 as similarly performed in 2.3. Cells
were maintained for 24 hours in regular culture media,
after which they were cultured in low glucose DMEM sup-
plemented with 10% FBS, 0.1 μM dexamethasone, 50 μM
ascorbate-2-phosphate, and 10 mM β-glycerophosphate
(all from Sigma) to induce osteogenic differentiation. The
induction culture was maintained for 3 weeks with full
medium changes every 3 days, whereas the control cells
were cultured for 3 weeks in low glucose DMEM with 10%
FBS. Experiments were performed in triplicate.
Following culture, 3 wells per group were stained with Ali-
zarin Red to visualize calcified deposits. Wells were gently
rinsed with PBS and then fixed with 70% ice-cold ethanol
for 1 hour. After washing with distilled water, Alizarin Red
solution (40 mM Alizarin Red-Tris-HCl, pH 4.1; Sigma)
was left at room temperature in wells for 10 minutes.
Wells were then extensively washed with distilled water to
remove any nonspecific staining, and the stained area was
quantified using ImageJ as in 2.4. For the remaining 3
wells per group, calcium cation (Ca2+) concentration was
determined via a colorimetric assay (Diagnostic Chemi-
cals, Charlottetown, PEI, Canada) as previously described
[41].
Statistical analyses
Analyses of variance (ANOVA) were performed using SAS
software (SAS Institute Inc., Cary, NC), followed by
Tukey's multiple comparison tests to determine pairwise
statistical significance within 95% confidence intervals (p
< 0.05). All results are reported as means ± standard devi-
ations. Due to quasi-complete separation, binary logistic
regression was not performed on the data for collagen II
staining of pellets.
Results
Postnatal BMSCs exhibit more rapid proliferation and 
greater attachment than BMSCs from aged donors
Following primary harvest, equal numbers of BMSCs were
plated in 6-well plates and attachment was measured over
24 hours. Overall, donor age was found to have a statisti-
cally significant effect on cell attachment (p < 0.0001). As
shown in Figure 1, at 8 hours and beyond there were sig-
nificant differences (p < 0.05) in attachment between cells
harvested from both 6-day and 6-week-old donors and
cells harvested from 1-year-old donors. Over 24 hours
there were no significant differences in attachment
between cells from 6 day and 6-week-old donors (p  >
0.05).
Proliferation was assessed for 8 days following primary
harvest. After 2 days there was significantly greater prolif-
eration among cultures harvested from 6-day-old donors
compared to cultures from 6-week and 1-year-old donors
(p < 0.05, Figure 2). This significant difference persisted
throughout the 8 days of culture. At 6 and 8 days, signifi-
cant differences in proliferation were also observed
between cultures from 6 week and 1-year-old donors (p <
0.05). Overall, donor age was found to have a statistically
significant effect on cell proliferation (p < 0.0001). There
was a 4.9 ± 0.2 fold increase in cell number in cultures of
postnatal BMSCs after 8 days compared to cell number
after 24 hours, and confluence in these cultures was
reached by day 6. An increase of 3.9 ± 0.2 and 3.0 ± 0.1
fold was observed in cultures from adult and aged donors
compared to cell numbers after 24 hours, respectively. For
the differentiation experiments, passage 1 cells had under-
gone approximately 2.7 cell doublings, while passage 6
cells had undergone 11.4 doublings. Cells from 6-day-old
donors doubled in approximately 2.3 days, with little var-
iation between passage 1 and 6, while cells from 6-week-
old and 1-year-old donors had approximate cell doubling
times of 3.1 and 3.5 days over the entire culture duration,
respectively.
Adipogenic potential is diminished in BMSCs from aged 
donors
To assess the adipogenic potential of BMSCs, Oil Red O
staining was quantified following 3 weeks of culture in
standard adipogenic media. Quantification was per-
formed in 2 ways, firstly by determining the percentage of
cells that contained Oil Red O stained lipid laden vacu-
oles, and secondly by determining the overall area within
a field of view that was stained by Oil Red O. Figure 3
shows results of both quantification methods along with
representative histology from each group.
Based on the percentage of cells staining positive for lipid
inclusions, there were no significant differences between
cells from 6-day and 6-week-old donors, and within theseBMC Cell Biology 2008, 9:60 http://www.biomedcentral.com/1471-2121/9/60
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groups there were no differences between cells at passage
1 or 6. A significantly lower percentage of cells stained
positive with Oil Red O was found in 1-year-old donors
comparing to passage matched numbers of 6-day and 6-
week groups (p < 0.05). Additionally, within 1-year old
group there was also a statistically significant difference
between passage 1 and passage 6 cells (52.9 ± 14.7 percent
versus 37.7 ± 8.9 percent, p < 0.05). Based on the percent-
age of cells stained, all groups were significantly different
from corresponding age and passage matched controls (p
< 0.05), and there were significant overall effects related to
both donor age (p < 0.0001) and cell passage (p < 0.05).
Additionally, there was a significant statistical interaction
effect (p < 0.05) between donor age and cell passage for
this method of quantifying adipogenic differentiation.
Quantifying the area stained with Oil Red O showed no
statistically significant differences in adipogenic differen-
tiation of BMSCs between 6-day and 6-week-old donors
when compared at the same passage (passage 1: 17.7 ± 4.2
percent versus 17.7 ± 4.4 percent, passage 6: 13.4 ± 3.3
percent versus 11.0 ± 3.9 percent, 6-day and 6-week
donors respectively). At the same passage, BMSCs from 1-
year-old donors revealed statistically significantly less adi-
pogenic staining area (passage 1: 8.1 ± 2.8 percent, pas-
sage 6: 5.2 ± 1.7 percent) than similarly passaged cells
from younger donors (p  < 0.05). For cells from aged
donors, there was also no significant effect of increased
passages (p > 0.05), whereas in the other two donor age
groups, passage significantly decreased the area stained (p
< 0.05). In all groups BMSCs displayed significantly differ-
ent stained areas than age and passage matched controls
(p < 0.05) except for passage 6 BMSCs from 1-year-old
donors (5.2 ± 1.7 percent vs. 2.3 ± 1.6 percent stained, p >
0.05). Significant overall effects were determined for
donor age (p < 0.0001) and cell passage (p < 0.0001);
however, there was no statistically significant interaction
between donor age and passage based on the area stained
(p > 0.05).
Chondrogenic potential decreases with age and repeated 
passage abrogates chondrogenic differentiation in aged 
donors
Sulfated glycosaminoglycan content was quantified for
pellets cultured for 3 weeks in chondrogenic media. As
shown in Figure 4, compared across donor age groups at
constant passage, sulfated GAG content per pellet signifi-
cantly decreased with each progressive increase in donor
BMSC Attachment Figure 1
BMSC Attachment. Results from the 24-hour assessment of BMSC attachment immediately following harvest. The '#' sign 
indicates significant differences between cells harvested from both 6-day and 6-week-old mice and those harvested from 1-
year-old mice. Error bars designate means ± standard deviation (n = 3, p < 0.05).BMC Cell Biology 2008, 9:60 http://www.biomedcentral.com/1471-2121/9/60
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age (p < 0.05). Increased passage of cells yielded statisti-
cally significant differences within donor age matched
groups only for BMSCs from 1-year-old donors (2.9 ± 1.2
μg per pellet versus 0.6 ± 0.6 μg per pellet, p < 0.05). Addi-
tionally, passage 6 BMSCs from 1-year-old donors did not
display significantly more sulfated GAG per pellet than
passage and donor age matched controls (1-year, passage
6 control: 0.1 ± 0.1 μg per pellet, p > 0.05). All other
groups had significantly greater GAG content per pellet
than passage and age matched controls (p < 0.05). Over-
all, donor animal age (p < 0.005) but not cell passage (p >
0.1) was found to have a significant affect on the amount
of sulfated GAG per pellet.
To further evaluate chondrogenesis, pelleted tissue was
immunohistochemically stained for collagen II. As shown
in Table 1, with the increase of donor age and cell passage,
the number of collagen II-positive pellets decreased. In
addition, a typical lacunar structure was observed in his-
tology of collagen II-positive pellets as shown in Figure 4.
Osteogenic potential decreases with age and passage only 
affects postnatal-harvested BMSCs
Osteogenic potential was determined by quantifying the
percent area stained with Alizarin Red, a dye that stains
calcium deposition, and by determining the amount of
extracellular calcium within a well. Both measures
showed that within age groups, the only statistically sig-
nificant difference based on passage was found in BMSC
cultures from postnatal donors (Figure 5, p < 0.05), where
passage 1 cultures displayed 46.7 ± 9.0 percent area
stained and 0.27 ± 0.06 mM Ca2+ versus 31.1 ± 10.1 per-
cent area stained and 0.2 ± 0.04 mM Ca2+ for passage 6
cultures. BMSCs from 6-week-old and 1-year-old donors
did not show significant differences in osteogenic poten-
tial for cultures at different passages. For both passage 1
and passage 6 cultures, an overall decreased osteogenic
potential was found with increased donor age for all ages
of donor in terms of both area and calcium content (p <
0.05). Tukey's multiple comparison tests revealed a signif-
icant difference of any two passage-matched groups com-
parisons in either stained area or calcium content (p <
0.05), except for passage 6 stained area between 6-day-old
and 6-week-old donors (31.1 ± 10.1 percent versus 27.2 ±
8.0 percent, p > 0.05). Representative micrographs show-
BMSC Proliferation Figure 2
BMSC Proliferation. Results from the 8-day assessment of BMSC proliferation during primary cell expansion. The '‡' symbol 
indicates significant differences between cells harvested from 6-day-old mice and all older donors. The '*' symbol indicates sig-
nificant differences between groups from all donors. Error bars designate means ± standard deviation (n = 3, p < 0.05).BMC Cell Biology 2008, 9:60 http://www.biomedcentral.com/1471-2121/9/60
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Figure 3 (see legend on next page)BMC Cell Biology 2008, 9:60 http://www.biomedcentral.com/1471-2121/9/60
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ing Alizarin Red stained samples are also displayed in Fig-
ure 5. The percent area stained using Alizarin Red was
significantly different from age and passage matched con-
trols (p < 0.05); however, the calcium assay showed no
significant difference between control and induced groups
for both passage 1 and 6 BMSC cultures of 1 year old
donors (p > 0.05). Analysis of both stained area and cal-
cium content showed a significant effect of donor age (p <
0.001); however, analysis of stained area showed a signif-
icant overall effect for passage (p < 0.001) while analysis
of calcium content did not show an overall effect for pas-
sage (p > 0.05). No statistically significant interaction was
found between donor age and passage for either method
of evaluation of osteogenic differentiation.
Discussion
In the present study, we investigated the effects of both
donor age and passage on murine BMSC differentiation
potentials towards adipogenic, chondrogenic, and osteo-
genic lineages. Murine BMSCs were used to facilitate
future studies performed in vivo, where implantation of
tissue engineering constructs containing fluorescently
labeled progenitor cells allows histologic determination
of the cell source for regenerated tissues [42-45]. Addi-
tionally, the availability of transgenic mice and mouse cell
lines presents the opportunity for tissue engineers to
investigate emerging strategies in more clinically appro-
priate disease models [46]. It is important, however, to
note that transgenic animals do not uniformly express
GFP, and this expression is variable between tissues with
values for murine bone marrow reported at close to 90%
[47] in some studies but significantly lower in others [48],
thus necessitating a careful comparison of light and fluo-
rescence microscopy when cell numbers are quantified.
Routine flow cytometric characterization of the breeder
colony used in this study has repeatedly shown over 90%
of adherent marrow cells express GFP, even after multiple
passages (unpublished data).
No standardized practice exists for the harvest, expansion,
and in vitro differentiation of BMSCs. As noted in the
Materials and Methods section, BMSCs in this study and
many others refers to the adherent marrow stromal cells
[16,36,49]. Within the adherent BMSC-containing popu-
lation, our data suggest that a more rapid decline occurs
in differentiation potential for osteoblastic and chondro-
genic lineages relative to the decline in adipogenic differ-
entiation.
We found that osteogenic and chondrogenic potentials
are adversely affected by increased donor age across all
three tested donor age groups, while adipogenic differen-
tiation potential is maintained in all but the aged donors
(1 year). These results are in agreement with previous
work which found that donor age affected osteogenic dif-
ferentiation of BMSCs more than it affected adipogenic
differentiation [24]. Analysis of the transcriptomes of
human BMSCs at passage 2 from young donors (average
age = 13) suggested that BMSCs should preferentially
form bone and cartilage over adipose tissue [36]. Peng et
al. recently found similar results, noting that expression of
osteogenesis-related genes peaked very early following
induction in BMSCs [50]. Other studies addressed the
hypothesis that age related decreases in bone regeneration
were due to BMSC aging, resulting in a decreased osteo-
genic potential with a concurrent increase in adipogenic
potential [8]. In this study BMSCs maintained their poten-
tial for adipogenic differentiation in early aging but exhib-
ited decreased potential for chondrogenic and osteogenic
differentiation, and, although no absolute increase in adi-
pogenic potential was observed with increasing age, the
relative differences between differentiation potentials
with age would thus favor adipogenesis over osteogenesis
and chondrogenesis. Age related cellular dysfunction has
been hypothesized to be the cause of multiple diseases of
bone and cartilage associated almost exclusively with
aging including osteoarthritis and osteoporosis, and loss
of progenitor cell differentiation potential could contrib-
ute to these diseases [51]. The present study supports
these hypotheses.
The effect of in vitro culture period prior to the induction
of differentiation was also investigated by expanding cells
through 6 passages and comparing differentiation to cells
Adipogenic Differentiation Figure 3 (see previous page)
Adipogenic Differentiation. Results of adipogenic differentiation after 3 weeks. (A) Representative micrographs showing Oil 
Red O stained lipid inclusions in cultured BMSCs from each experimental group. Magnification bars represent 100 μm in all 
images. (B) Percentage of cells that had intracellular Oil Red O stained inclusions after 3 weeks. Passage related significant dif-
ference in staining was only observed in BMSC cultures from 1-year-old donors (p < 0.05). (C) Percentage of total area that 
was positively stained with Oil Red O. Passage related significant differences were observed for BMSC cultures from 6-day and 
6-week-old donors, and age related differences were only observed between 1-year-old donors and the other groups. The '#' 
sign indicates a significant difference between passage 1 and passage 6 cultures from similarly aged donors, '‡' indicates a signif-
icant difference between the indicated group and any passage 1 groups from younger donors, and '¥' indicates a significant dif-
ference between the indicated group and any passage 6 groups from younger donors (p > 0.05). Error bars designate means ± 
standard deviation (n = 6).BMC Cell Biology 2008, 9:60 http://www.biomedcentral.com/1471-2121/9/60
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Chondrogenic Differentiation Figure 4
Chondrogenic Differentiation. Results of chondrogenic differentiation of pelletted micromasses after 3 weeks. (A) Repre-
sentative micrographs of differentiated micromasses from passage 1 cells of 6-day-old donors. Safranin O (left), hematoxylin 
and eosin (middle), and immunohistochemical staining for collagen II (right) staining were used to show the morphological struc-
ture and biochemical components of induced pellets. The inset demonstrates the lacunar morphology typically observed in car-
tilage. Magnification bars represent 100 μm in all images. (B) Micrograms of sulfated GAG per pellet. The '#' sign indicates a 
significant difference between passage 1 and passage 6 cultures from similarly aged donors, '‡' indicates a significant difference 
between the indicated group and any passage 1 groups from younger donors, and '¥' indicates a significant difference between 
the indicated group and any passage 6 groups from younger donors (p < 0.05). At a constant number of passages, significant dif-
ferences were found across all age groups. Passage related differences were only significant in BMSCs from 1-year-old donors. 
Error bars designate means ± standard deviation (n = 3).BMC Cell Biology 2008, 9:60 http://www.biomedcentral.com/1471-2121/9/60
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after a single passage. For chondrogenesis, increased pas-
sage only affected cells from 1-year-old donors, rendering
them equal to control groups at the level of significance (p
> 0.05). For osteogenesis, the opposite effect was
observed; a difference in osteogenesis due to passage
alone was only observed in BMSC cultures from postnatal
mice. Previous work using human BMSCs observed a
greater passage related decrease in osteogenic differentia-
tion in cells from young donors compared to cells from
aged donors [16]. Early passage postnatal BMSCs may be
preferentially inclined towards osteogenesis and this pref-
erence may be quickly eliminated with repeated passages
and aging, leading to the observed differences between
passage 1 postnatal BMSCs and all other groups with
respect to osteogenic differentiation.
The effect of passage on adipogenesis was more obscure.
Quantifying the percentage of cells stained with Oil Red O
showed significant passage related differences only in cul-
tures from aged donors, whereas quantifying the percent-
age area stained showed significant differences in cultures
from postnatal and adult donors but not those from aged
mice. A previous study investigating adipogenic differen-
tiation with increasing BMSC passages found that the size
of adipocytes decreased with increased passage [16]. Thus
for postnatal and adult derived BMSCs, passage related
changes in area might be largely due to decreased cell vol-
ume rather than a decrease in the number of differentiated
cells. In cultures of BMSCs from aged donors, the rela-
tively decreased number of cells undergoing adipogenic
differentiation may render this effect statistically insignif-
icant at the designated sample size (n = 6). When charac-
terizing adipogenic differentiation via quantification of
the percentage of cells stained with Oil Red O, the statisti-
cally significant interaction effect of donor age and pas-
sage reflects that cultures from aged donors were the only
group to be both significantly decreased from other age
groups and to have a significant decrease in cells stained
between passage 1 and passage 6 cultures. This may reflect
a loss of adipogenic differentiation capacity only experi-
enced by MSCs from aged donors that is not detected
when quantifying the stained area due to passage-related
decreases in adipocyte size experienced in cultures from
all donors. It is also important to note that the selected
adipogenic cocktail utilized indomethacin, a commonly
used chemical for these applications that inhibits cycloox-
ygenase. Indomethacin has been shown to both positively
and negatively effect PPARγ in a concentration dependent
manner [52]. Although adipogenic differentiation can be
induced via PPARγ dependent and independent signaling
[53], PPARγ 2 activation may be critical in BMSC differen-
tiation as this pathway promotes terminal differentiation
and suppresses Osf2/Cbfa1 [54]. A PPARγ ligand such as
rosiglitazone may therefore be a more ideal component
for adipogenic induction media for BMSCs.
Working with human BMSCs, Banfi et al. found decreased
adipogenic, chondrogenic, and osteogenic potentials
when increasing from passage 1 to passage 5 and found
adipogenic potential to be compromised prior to osteo- or
chondrogenic potential [32]. In the present study, passage
effects were variable when considered along with specific
donor ages. For example, for 6-week-old donors, osteo-
genesis and chondrogenesis were unaffected by passage,
but adipogenesis as measured by percent area stained was
significantly decreased with increased passage. These
results correlate well to published studies using human
BMSCs [32,34]; however, it should be noted that due to
the use of biochemical characterization methods in addi-
tion to histology to characterize osteogenic and chondro-
genic differentiation, the sample size for these methods
was smaller (n = 3) than for evaluation of adipogenic dif-
ferentiation (n = 6). Passage adversely affected osteogenic
potential in BMSCs from postnatal donors, while chon-
drogenesis was only diminished by passage in BMSCs
from 1-year-old donors, suggesting differences in passage
effects for different differentiation lineages at different
ages. When evaluating changes associated with passage, it
is important to note that the adherent marrow stroma is a
heterogeneous cell population, therefore there is concern
that changes attributed to altered MSC function could
actually be due to the preferential proliferation of one or
several type(s) of cell(s) over others. The observed varia-
ble effects of passage with age suggest that different or
additional factors other than BMSC number and differ-
ences in attachment/proliferation contribute to differ-
ences in differentiation potential, as, in the case that
heterogeneity and subsequent differential proliferation,
one would expect effects due to frequency or proliferation
to be exhibited across all lineages.
Conclusion
Based on the results of this study and many other previous
studies, it appears that many variables must be considered
when choosing an ideal or appropriate cell source for a
specific application. Future studies should address tissue
regeneration in vivo, as this will allow parameters such as
aging and passage to be compared using criteria more
closely related to the clinical goal of regenerating
destroyed or dysfunctional tissues. As more is learned
regarding aging and passage of adult stem cells, it may be
Table 1: The ratio of collagen II positive pellets to pellets 
cultured per group, denoted as x:3, where x is the number of 
pellets staining positively for collagen II
6 Day 6 Week 1 Year
Passage 1 3/3 3/3 1/3
Passage 6 3/3 2/3 0/3BMC Cell Biology 2008, 9:60 http://www.biomedcentral.com/1471-2121/9/60
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Osteogenic differentiation Figure 5
Osteogenic differentiation. Results of osteogenic differentiation after 3 weeks. (A) Representative micrographs showing 
Alizarin Red stained mineral deposits on cultured BMSCs from each experimental group. Magnification bars represent 100 μm 
in all images. (B) Percentage of total area viewed that was positively stained with Alizarin Red. (C) Quantified calcium cation 
(mM) determined using a colorimetric calcium assay. For B and C, The '#' sign indicates a significant difference between passage 
1 and passage 6 cultures from similarly aged donors, '‡' indicates a significant difference between the indicated group and any 
passage 1 groups from younger donors, and '¥' indicates a significant difference between the indicated group and any passage 6 
groups from younger donors (p < 0.05). Age-related decreases in staining and calcium were significant across all age groups, 
and significant passage related decreases were only observed in BMSCs from 6-day-old donors. Error bars designate means ± 
standard deviation (n = 3).BMC Cell Biology 2008, 9:60 http://www.biomedcentral.com/1471-2121/9/60
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determined that a certain population of cells is more
appropriate for specific therapies based on patient age and
the tissue of interest. While the present study offers little
in the way of mechanistic explanations for the observed
phenomena, it provides one of the first analyses of age in
combination with passage in an animal model that will be
useful for developing future tissue engineering strategies.
There is little doubt that aging of adult stem cells plays a
role in the spectrum of changes during normal aging and
that consideration of age and passage in combination will
prove to be critical to the success of any strategy that seeks
to regenerate tissue through the use of implanted progen-
itor cells.
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